Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel ...

Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infectives ...

Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The ...

Microbes often display cooperative behavior in which individual cells put in work and sacrifice resources to collectively ...

Pathogens can create sticky situations. When microbes invade the body to cause an infection, often one of their first lines ...

Studies published in Nature Cancer reveal how bacterial presence in head and neck cancers affects treatment response, ...

Certain antibodies employ unusual tactics to keep germs from attaching to cells in our bodies. Their defensive strategies ...

New study reveals that bacteria can survive antibiotic treatment through two fundamentally different "shutdown modes," not ...

Drugs that limit the activity of cells called neutrophils could make heart attacks less severe without compromising the ...

From saccharin in the 19th century to stevia and monk fruit in the 21st, researchers and the food industry have long sought a sweetener that delivers the taste of sugar without its drawbacks—excess ...